Paul, they get only $10 per test, the market cap is north of $200 MM right now, since they themselves do not see much more than 3 to 5 MM tests per year, is not the enthusiasm a little "overdone"? I got to learn more about this outfit. It is an Irish company, making it difficult to "understand" (for me).
From a recent PR:
"We believe that this success can be replicated in the USA where there is an incidence of 40,000 new HIV infections annually.
Experience in CDC funded HIV programmes has shown that up to 40% of those tested for HIV using conventional lab based tests
will not return for their results. The rapid test allows for on-the-spot results that can increase the diagnosis of infected people.
The conversion of these lab based HIV tests to rapid products represents an estimated annual market opportunity of 3 million
tests or $30 million."